Direct Factory Supply with Complete Regulatory Dossiers (GMP, ISO, CEP) for Georgian Pharmaceutical and Industrial Applications.
The Trans-Caucasus region, with Georgia serving as its premier logistics and industrial nexus, is undergoing a profound structural evolution across its pharmaceutical manufacturing, clinical biotechnology, and high-performance agricultural sectors. Situated strategically along the Middle Corridor connecting Europe and Asia, Georgia has developed into an attractive operational hub for active pharmaceutical ingredient (API) processing, biological formulation, and veterinary chemical synthesis.
Central to this technological expansion is the global demand for ultra-pure Cholic Acid series products. Cholic acid (3α,7α,12α-trihydroxy-5β-cholan-24-oic acid) and its conjugated derivatives represent foundational steroidal building blocks. These compounds act as vital signaling molecules, therapeutic agents for hepatobiliary disorders, biological detergents for viral inactivation and membrane protein extraction, as well as crucial emulsifiers in advanced animal nutrition.
This comprehensive white paper presents a definitive technical roadmap, industrial framework, and regulatory breakdown for biopharmaceutical companies, research institutions, and feed additive manufacturers seeking primary factory supply of Cholic Acid derivatives tailored for the Georgian market.
Understanding the molecular dynamics, synthesis pathways, and therapeutic specifications of bile acid chemistry.
Cholic Acid (CA) [CAS 81-25-4] and Chenodeoxycholic Acid (CDCA) [CAS 474-25-4] form the cornerstone of primary hepatic bile acid biosynthesis. Produced via the classic CYP7A1 hydroxylase pathway in mammals, these molecules possess a hydrophobic steroid nucleus combined with hydrophilic hydroxyl groups. In pharmaceutical production across Georgia, high-purity Cholic Acid (≥98.5% assay via HPLC) acts as the fundamental raw precursor for synthesizing Obeticholic Acid (OCA) and secondary bile acid conjugates used to treat metabolic and cholestatic liver diseases.
Ursodeoxycholic Acid (UDCA) [CAS 128-13-2] and Deoxycholic Acid (DCA) [CAS 83-44-3] offer distinctive physiological profiles. UDCA features a 7β-hydroxyl epimer structure, conferring anti-apoptotic, membrane-stabilizing, and cytoprotective properties. It is widely manufactured into solid dosage oral forms in Caucasus region clinics. Deoxycholic acid and its sodium salt (Sodium Deoxycholate [CAS 302-95-4]) serve critical functions as biological detergents in recombinant protein isolation and aesthetic submental fat cytolysis injections.
Conjugation with taurine dramatically increases water solubility and physiological bio-availability. Tauroursodeoxycholic Acid (TUDCA) [CAS 14605-22-2] and Taurochenodeoxycholic Acid Sodium Salt [CAS 6009-98-9] suppress endoplasmic reticulum (ER) stress, making them prime candidates for neuroprotective therapeutic research, ocular therapeutics, and specialized viral vaccine production protocols operating in Eastern European research ecosystems.
Dehydrocholic Acid [CAS 81-23-2], derived via oxidation of cholic acid, functions as a powerful hydrocholeretic agent, stimulating the liver to produce high-volume fluid bile. Concurrently, standardized Ox Bile Powder extracts provide complex mixtures of conjugated bile salts essential for formulating digestive enzymotherapy tablets and agricultural feed supplements aimed at optimizing lipid digestion in intensive livestock farming.
To maximize commercial value and technical alignment, our Cholic Acid series products are structured to support three key economic pillars in Georgia:
Georgian pharmaceutical companies are rapidly expanding their oral solid dose (OSD) manufacturing footprint to serve domestic needs and regional export networks across CIS and Southern European markets. Our USP/Ph. Eur. grade Ursodeoxycholic Acid and Cholic Acid provide guaranteed low-impurity profiles (<0.1% individual related substances), ensuring rapid formulation into capsules and tablets designed for cholestatic liver disease, non-alcoholic fatty liver disease (NAFLD), and gallstone dissolution therapy.
Agriculture remains a pivotal sector of Georgia's economy. High-density poultry integration in Kakheti, swine production in Imereti, and emerging cold-water trout aquaculture along mountain river basins demand enhanced nutrient utilization. Incorporating standardized Ox Bile Powder and feed-grade Sodium Deoxycholate into animal diets enhances lipid emulsification, protects liver function against endo- and mycotoxins, and elevates feed conversion ratios (FCR) by up to 8.5%.
With major investments in public health research infrastructure and scientific academia in Tbilisi, high-purity biological detergents like Sodium Tauroursodeoxycholate and Dehydrocholate Sodium are increasingly required for membrane protein crystallization, ELISA test kit production, and viral inactivation protocols in biopharmaceutical downstream purification.
Comprehensive Quality Systems Backed by International Certifications and Full Batch Traceability.
Our manufacturing matrix operates under rigorous quality management systems aligned with EU cGMP and global regulatory expectations. Every batch of Cholic Acid series material shipped to Poti or Batumi ports, or delivered via air freight to Tbilisi International Airport, undergoes extensive analytical testing prior to release.
From laboratory pilot synthesis to commercial-scale supply in 7 streamlined steps.
Consultation on exact specifications, particle sizes, purity grades, and delivery schedules.
Detailed cost breakdown based on quantity tiers, packaging specs, and shipping terms (FOB/CIF Poti).
Formal agreement with strict NDA and quality guarantee clauses to protect partner IP.
Synthesis and dispatch of trial samples for customer lab verification and analytical testing.
Full-scale manufacturing scheduled in cleanrooms utilizing advanced enzymatic reactors.
Final analytical testing, issuance of COA, and custom barrier packaging implementation.
Efficient shipping via air express or sea freight straight to your destination facility in Georgia.
Ongoing technical assistance, re-order optimization, and regulatory filing update services.
As sustainability regulations intensify across Europe and Eurasia, classical extraction methods for bile acids are undergoing a major transition toward synthetic biology and enzymatic biotransformation. Traditional extraction relying solely on animal-derived bile faces environmental and supply chain volatility.
Our R&D pipeline is aggressively committed to green synthesis protocols:
Explore our extended derivative range available for bulk supply, private labeling, and custom formulation for Georgia.
Addressing core technical, regulatory, and supply chain queries for buyers and researchers in Georgia.
Our high-grade Cholic Acid (CAS 81-25-4) is manufactured with a minimum assay of 98.0% to 99.5% verified via High-Performance Liquid Chromatography (HPLC). We supply both pharmaceutical-grade raw materials meeting EP/USP standards and industrial-grade compounds suited for diagnostic kit formulation.
To prevent moisture absorption and degradation during trans-Eurasian transport, our products are packaged in double food/pharma-grade polyethylene inner liners sealed inside 25 kg fiber drums or heavy-duty aluminum foil bags for smaller batches. Special nitrogen-flushing option is available upon request.
Yes. Our R&D team provides specialized contract synthesis for taurine- and glycine-conjugated bile acids including Tauroursodeoxycholic Acid (TUDCA), Taurochenodeoxycholic Acid Sodium Salt, and Sodium Deoxycholate. We tailor micronization, solubility profiles, and bulk densities to your exact specifications.
Every shipment is dispatched with a comprehensive document packet including Certificate of Analysis (CoA), Safety Data Sheet (SDS / MSDS), Certificate of Origin (COO), Packing List, Commercial Invoice, and BSE/TSE-Free Certificates where applicable to ensure rapid processing through Georgian customs authorities.
Chenlv Herb
